Base contract title: preclinical in vitro and in vivo agent development assays, task order title: a polyvalent vaccine against fusion proteins observed in solid tumors, period of performance: august…

Ended Awarded Last action

Contract number
HHSN26100006
Awardee
Awarding agency
Obligated
$455,960

Award facts

Contract value 100% obligated
$455,960.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
New York, NY 10065, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 -$2,675
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $458,635

Description

As the agency reported it.

Base contract title: preclinical in vitro and in vivo agent development assays, task order title: a polyvalent vaccine against fusion proteins observed in solid tumors, period of performance: august 29, 2014 through august 28, 2016

Quick answers

Who was awarded contract HHSN26100006?

HHSN26100006 was awarded to Weill Medical College Of Cornell University by National Cancer Institute (National Institutes of Health) on August 29, 2014.

How much is contract HHSN26100006 worth?

The government has obligated $455,960 on HHSN26100006.

Is contract HHSN26100006 an order under another contract?

Yes. HHSN26100006 is a delivery order under HHSN261201200018I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.

Was contract HHSN26100006 competed?

The extent of competition for HHSN26100006 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login